Assisted Living Facilities (ALFs)
At NivoGenetics, we focus on supporting assisted living facilities and nursing homes with advanced pharmacogenomic testing solutions. For facilities managing patients dealing with polypharmacy, our services are crucial in enhancing care quality while optimizing treatment effectiveness.
Adverse drug reactions (ADRs) are a significant risk factor for older adults, ranking as the 4th leading cause of death. Pharmacogenomics (PGx) helps facilities assess genetic profiles to reduce harmful reactions.
PGx testing helps doctors prescribe safer, more effective medications, reducing side effects and improving outcomes. Since DNA is constant, a PGx test offers lifelong insights for ongoing care.
Our pharmacogenomic services provide clear benefits to assisted living facilities
1
Tailored medication plans improve safety, quality of life, and overall health outcomes.
2
Reduce unnecessary hospitalizations and adverse events, leading to smoother facility management.
3
Partnering with NivoGenetics generates additional revenue streams for your facility with no extra cost.
4
We offer seamless integration into your care protocols, providing staff training, ongoing support, and detailed result interpretations.
Residents over 65 are at higher risk of hospitalization due to adverse drug effects. As we age, our bodies undergo changes that impact medication processing:
For seniors, some medications may pose unnecessary risks. High-risk medications can lead to cognitive decline, falls, and fractures.
Choosing safer alternatives can significantly enhance resident safety and well-being.
Implementing pharmacogenomics in your facility can elevate your care standards while offering clear operational benefits
Ensure each resident receives medications best suited to their unique genetic profile.
Minimize the financial burden of unnecessary or ineffective treatments.
Differentiate your facility as a leader in advanced, personalized care.
